| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 Mdm2: keeping p53 under control Piette J; Neel H; Marechal VOncogene  1997[Aug]; 15 (9): 1001-10The Mdm2 gene is overexpressed in several human tumors. The oncogenic potential  of Mdm2 is partially explained by the inhibition of the activity of the tumor  suppressor protein p53. Determination of the three-dimensional structure of  complexes between Mdm2 and the N-terminal p53 peptide provided a molecular basis  for the inhibition of the transcriptional function of p53 by Mdm2. More  dramatically, p53 is targeted by Mdm2 for rapid degradation. The Mdm2 gene itself  is activated by p53, which gives the opportunity for feed-back control of p53  activity. Keeping p53 under control is most likely the major task of Mdm2 during  early development. Recently, evidence was provided for an alternative,  p53-independent function of Mdm2.|*Nuclear Proteins[MESH]|Amino Acid Sequence[MESH]|Animals[MESH]|Gene Expression Regulation, Neoplastic/drug effects[MESH]|Humans[MESH]|Molecular Sequence Data[MESH]|Neoplasm Proteins/chemistry/genetics/*physiology[MESH]|Proto-Oncogene Proteins c-mdm2[MESH]|Proto-Oncogene Proteins/chemistry/genetics/*physiology[MESH]|Structure-Activity Relationship[MESH]|Tumor Suppressor Protein p53/chemistry/genetics/*physiology[MESH]
 |